Gemstone Biotherapeutics

About:

Gemstone Biotherapeutics is a pre-clinical research and development initiative.

Website: http://www.gemstonebio.com/

Twitter/X: GemThera

Top Investors: National Science Foundation, University System of Maryland Momentum Fund, Gamma3

Description:

Gemstone Biotherapeutics is a pre-clinical research and development initiative based in Baltimore, Maryland. Gemstone is dedicated to the field of regenerative medicine and specializes in developing improved methods for advanced wound healing and tissue vascularization using licensed technology from Johns Hopkins University. Their core technologies include innovative polymeric hydrogels and stem cell engineering methodologies.

Total Funding Amount:

$2.78M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)gem-bio.com

Founders:

George Davis

Number of Employees:

1-10

Last Funding Date:

2019-08-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai